MetaADEDB 2.0 @ LMMD
benfluorex
(CJAVTWRYCDNHSM-UHFFFAOYSA-N)
Structure
SMILES
CC(Cc1cccc(c1)C(F)(F)F)NCCOC(=O)c1ccccc1
Type(s)
Investigational; Withdrawn
ATC code(s)
A10BX06
Molecular Formula:
C19H20F3NO2
Molecular Weight:
351.363
Log P:
4.4739
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
1
TPSA:
38.33
CAS Number(s):
23602-78-0
Synonym(s)
1.
benfluorex
2.
1-(2-trifluoromethylphenyl)-2-(benzoyloxyethyl)aminopropane HCl
3.
780 SE
4.
JP 992
5.
S 780
6.
SE 780
7.
benfluorex hydrochloride
8.
benfluorex hydrochloride, (+-)-isomer
9.
benfluorex maleate
10.
benfluorex, methanesulfonate salt
11.
benfluramate
External Link(s)
MeSHC001584
PubChem Compound2318
ChEBI93826
CHEMBLCHEMBL400599
DrugBankDB09022
DrugCentral307
KEGGdr:D07192
Therapeutic Target DatabaseD07XCF
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Altered state of consciousnessOFFSIDES
2AngioedemaOFFSIDES
3AnisocytosisOFFSIDES
4Ankylosing spondylitisOFFSIDES
5AnorexiaOFFSIDES
6Aortic Valve Insufficiency12605770CTD
7ApathyOFFSIDES
8AstheniaOFFSIDES
9Atrial tachycardiaOFFSIDES
10Atrioventricular BlockOFFSIDES
11AuraOFFSIDES
12BicytopeniaOFFSIDES
13Blood amylase increasedOFFSIDES
14Blood creatinine increasedOFFSIDES
15Blood glucose abnormalOFFSIDES
16Blood lactate dehydrogenase increasedOFFSIDES
17Blood sodiumOFFSIDES
18Bone marrow depressionOFFSIDES
19Bone marrow myelogram abnormalOFFSIDES
20Brain natriuretic peptide increasedOFFSIDES
21BronchitisOFFSIDES
22Cardiac TamponadeOFFSIDES
23Congenital tricuspid valve incompetenceOFFSIDES
24Conjunctival depositOFFSIDES
25Cytolytic hepatitisOFFSIDES
26Diabetes mellitus inadequate controlOFFSIDES
27Disseminated Intravascular CoagulationOFFSIDES
28Ejection Fraction DecreasedOFFSIDES
29Ejection fraction abnormalOFFSIDES
30Gamma-Glutamyltransferase IncreasedOFFSIDES
31Gastric ulcerOFFSIDES
32Gastrointestinal mucosal disorderOFFSIDES
33General physical health deteriorationOFFSIDES
34GlobulinuriaOFFSIDES
35Hepatojugular refluxOFFSIDES
36Hilar lymphadenopathyOFFSIDES
37HypoxiaOFFSIDES
38IncontinenceOFFSIDES
39Injection site vesiclesOFFSIDES
40LipaseOFFSIDES
41LymphedemaOFFSIDES
42Lymphocyte count decreasedOFFSIDES
43Mental disorders19637435CTD
44Metastatic NeoplasmOFFSIDES
45Mitral Valve Insufficiency12605770CTD
46Mucosal erosionOFFSIDES
47Optic Disc EdemaOFFSIDES
48Oropharyngeal candidiasisOFFSIDES
49Pericardial effusionOFFSIDES
50PericarditisOFFSIDES
51PeritonitisOFFSIDES
52PolyneuropathyOFFSIDES
53ProctocolitisOFFSIDES
54Prothrombin level decreasedOFFSIDES
55Pulmonary HypertensionOFFSIDES
56Pulmonary arterial hypertensionOFFSIDES
57Pustular psoriasisOFFSIDES
58SclerodermaOFFSIDES
59Stevens-Johnson SyndromeOFFSIDES
60SubileusOFFSIDES
61Transaminases increasedOFFSIDES
62TrichiasisOFFSIDES
63Tricuspid Valve Insufficiency12605770CTD
64Ventricular hypokinesiaOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.